Abstract

D-Amino acids, long-term undetected enantiomers of L-amino acids, are now emerging as potential biomarkers, especially for kidney diseases. Management of chronic kidney disease (CKD), a global problem with its high prevalence and poor prognosis, is currently unsatisfactory due to the difficulty in estimating kidney function and in early detection of diseases. We now show that intra-body dynamics of D-serine reflect kidney function and diseases. The blood level of D-serine correlated well with the actual glomerular filtration ratio, a key kidney function. This correlation was compatible with those of conventional kidney markers, and blood level of D-serine was relatively unaffected by such clinical factors as body size. The balance between excretion and reabsorption of amino acids by the kidney was controlled with chiral selectivity, and the reabsorption of D-serine was sensitive to the presence of CKD. The combination of blood level and urinary dynamics of D-serine effectively distinguished CKD from non-CKD. These lines of evidence provide new insights into the enantioselective amino acid dynamics in the human body that reflect disease pathophysiology. D-Serine may serve as a vital biomarker that suppress CKD onset through the precise assessment of kidney function and the diagnosis of CKD.

Details

Title
D-Serine reflects kidney function and diseases
Author
Hesaka Atsushi 1 ; Sakai Shinsuke 2 ; Hamase Kenji 3 ; Ikeda Tatsuhiko 4 ; Matsui Rakan 4   VIAFID ORCID Logo  ; Mita Masashi 4 ; Horio Masaru 5 ; Isaka Yoshitaka 2 ; Kimura Tomonori 6 

 KAGAMI Project, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan; Reverse Translational Project, Center for Rare Disease Research, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan; Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Kyushu University, Graduate School of Pharmaceutical Sciences, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 KAGAMI LAB., Incubation Center, Shiseido Co., Ltd., Tokyo, Japan (GRID:grid.419168.3) (ISNI:0000 0004 0641 1476) 
 Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University Graduate School of Medicine, Department of Functional Diagnostic Science, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 KAGAMI Project, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan (GRID:grid.136593.b); Reverse Translational Project, Center for Rare Disease Research, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan (GRID:grid.136593.b); Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2197742562
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.